Table 3 Complications, Treatment and Outcome in pediatric patients infected with Covid-19, Influenza A and Influenza B
Covid-19 (N = 248) | A influenza (N = 188) | B influenza (N = 149) | P Value | |
|---|---|---|---|---|
Treatment | ||||
Antiviral therapy | 50 (20.16%) | 86 (45.74%) | 65 (43.62%) | < 0.0001 |
Antibiotic therapy | 109 (43.95%) | 166 (88.30%) | 143 (95.97%) | < 0.0001 |
Use of corticosteroid | 3 (1.21%) | 23 (12.23%) | 13 (8.72%) | 0.0001 |
Interferon α | 235 (94.76%) | 22 (11.70%) | 13 (8.72) | < 0.0001 |
Immunoglobulin | 1 (0.40%) | 4((2.13%) | 5 (3.36%) | 0.0774 |
ICU | 4 (1.61%) | 14 (7.45%) | 4 (2.68%) | 0.0043 |
Oxygen support | ||||
Nasal cannula | 3 (1.21%) | 28 (14.89%) | 15 (10.07%) | < 0.0001 |
Invasive mechanical ventilation | 4 (1.61%) | 6 (3.19%) | 2 (1.34%) | 0.4164 |
Complications | ||||
Cardiac injury | 18 (7.26%) | 37 (19.68%) | 27 (18.12%) | 0.0002 |
Liver dysfunction | 13 (5.24%) | 7 (3.72%) | 3 (2.01%) | 0.2725 |
Acute gastroenteritis | 5 (2.02%) | 5 (2.66%) | 1 (0.67%) | 0.4017 |
Neutropenia | 0 | 8 (4.26%) | 9 (6.04%) | 0.0010 |
Lung injury | 0 | 6 (3.19%) | 0 | 0.0017 |
Renal injury | 2 (0.81%) | 1 (0.53%) | 0 | 0.5520 |
MODS | 2 (0.81%) | 2 (1.06%) | 0 | 0.4769 |
Clinical outcome | ||||
Discharge or in hospital | 247 | 188 | 149 | |
Death | 1 | 0 | 0 | |